TBX3 and mesenchymal cell neoplasm: Because strategies aimed at reactivating TBX3 in iCCA lesions might be harmful due to the risk of inducing mesenchymal tumors, TBX3 downstream targets whose inactivation is detrimental to biliary tumorigenesis should be unraveled.